[HTML][HTML] Post-COVID syndrome: the aftershock of SARS-CoV-2
A Dotan, Y Shoenfeld - International Journal of Infectious Diseases, 2022 - Elsevier
Significant time has passed since the coronavirus disease of 2019 (COVID-19) pandemic
outbreak, which led to severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) …
outbreak, which led to severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) …
[HTML][HTML] Anatomical barriers against SARS-CoV-2 neuroinvasion at vulnerable interfaces visualized in deceased COVID-19 patients
M Khan, M Clijsters, S Choi, W Backaert, M Claerhout… - Neuron, 2022 - cell.com
Can SARS-CoV-2 hitchhike on the olfactory projection and take a direct and short route from
the nose into the brain? We reasoned that the neurotropic or neuroinvasive capacity of the …
the nose into the brain? We reasoned that the neurotropic or neuroinvasive capacity of the …
[HTML][HTML] Insights into the recent 2019 novel coronavirus (SARS-CoV-2) in light of past human coronavirus outbreaks
Coronaviruses (CoVs) are RNA viruses that have become a major public health concern
since the Severe Acute Respiratory Syndrome-CoV (SARS-CoV) outbreak in 2002. The …
since the Severe Acute Respiratory Syndrome-CoV (SARS-CoV) outbreak in 2002. The …
[HTML][HTML] Single-nucleus transcriptome analysis of human brain immune response in patients with severe COVID-19
Abstract Background Coronavirus disease 2019 (COVID-19), caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, has been associated with …
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, has been associated with …
[HTML][HTML] The role of environmental factors on transmission rates of the COVID-19 outbreak: an initial assessment in two spatial scales
Abstract First identified in Wuhan, China, in December 2019, a novel coronavirus (SARS-
CoV-2) has affected over 16,800,000 people worldwide as of July 29, 2020 and was …
CoV-2) has affected over 16,800,000 people worldwide as of July 29, 2020 and was …
[HTML][HTML] Neuropathology and virus in brain of SARS-CoV-2 infected non-human primates
I Rutkai, MG Mayer, LM Hellmers, B Ning… - Nature …, 2022 - nature.com
Neurological manifestations are a significant complication of coronavirus disease (COVID-
19), but underlying mechanisms aren't well understood. The development of animal models …
19), but underlying mechanisms aren't well understood. The development of animal models …
Transmission heterogeneities, kinetics, and controllability of SARS-CoV-2
K Sun, W Wang, L Gao, Y Wang, K Luo, L Ren, Z Zhan… - Science, 2021 - science.org
INTRODUCTION The role of transmission heterogeneities in severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) dynamics remains unclear, particularly those …
syndrome coronavirus 2 (SARS-CoV-2) dynamics remains unclear, particularly those …
The duration of infectiousness of individuals infected with SARS-CoV-2
KA Walsh, S Spillane, L Comber, K Cardwell… - Journal of Infection, 2020 - Elsevier
Objectives To summarise the evidence on the duration of infectiousness of individuals in
whom SARS-CoV-2 ribonucleic acid is detected. Methods A rapid review was undertaken in …
whom SARS-CoV-2 ribonucleic acid is detected. Methods A rapid review was undertaken in …
In SARS-CoV-2, astrocytes are in it for the long haul
The most dire consequences of severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) infection may not manifest during the initial infection but appear later and are …
CoV-2) infection may not manifest during the initial infection but appear later and are …
[HTML][HTML] Epidemiology, genome, and clinical features of the pandemic SARS-CoV-2: a recent view
JM Abduljalil, BM Abduljalil - New microbes and new infections, 2020 - Elsevier
Since the emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
in Wuhan, China, the number of globally confirmed cases according to World Health …
in Wuhan, China, the number of globally confirmed cases according to World Health …